HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lélia Batista de Souza Selected Research

Pleomorphic Adenoma

12/2018Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.
6/2018Assessment of CTNNB1 gene mutations and β-catenin immunoexpression in salivary gland pleomorphic adenomas and adenoid cystic carcinomas.
8/2017Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.
6/2017Immunoexpression of GLUT-1 and angiogenic index in pleomorphic adenomas, adenoid cystic carcinomas, and mucoepidermoid carcinomas of the salivary glands.
1/2017Pleomorphic adenomas of the salivary glands: retrospective multicentric study of 130 cases with emphasis on histopathological features.
1/2017Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism.
1/2007Immunohistochemical expression of vimentin, calponin and HHF-35 in salivary gland tumors.
6/2006Tenascin and fibronectin in pleomorphic adenoma of the salivary gland.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lélia Batista de Souza Research Topics

Disease

32Neoplasms (Cancer)
09/2022 - 06/2006
10Odontogenic Cysts (Keratocyst)
09/2022 - 07/2004
8Pleomorphic Adenoma
12/2018 - 06/2006
7Ameloblastoma
07/2019 - 06/2007
6Dentigerous Cyst
10/2016 - 07/2004
5Radicular Cyst
01/2020 - 07/2004
5Odontogenic Tumors (Dental Tissue Neoplasm)
07/2019 - 09/2009
5Adenoid Cystic Carcinoma (Cylindroma)
12/2018 - 01/2007
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2016 - 07/2010
4Squamous Cell Carcinoma of Head and Neck
01/2022 - 02/2009
4Neoplasm Metastasis (Metastasis)
04/2016 - 02/2009
3Carcinogenesis
12/2022 - 03/2013
3Cysts
05/2018 - 07/2013
3Carcinoma (Carcinomatosis)
08/2017 - 09/2008
3Inflammation (Inflammations)
07/2013 - 07/2004
2Adenoameloblastoma
01/2019 - 06/2007
2Mucoepidermoid Carcinoma
06/2017 - 08/2006
2Actinic cheilitis
09/2016 - 09/2011
2Bone Resorption
07/2013 - 03/2012
2Disease Progression
03/2013 - 02/2012
2Periodontitis
01/2013 - 01/2013
2Basal Cell Nevus Syndrome (Gorlin Syndrome)
03/2012 - 07/2008
2Stomatitis
11/2006 - 04/2003
1COVID-19
11/2022
1Xeroderma Pigmentosum (Kaposi's Disease)
01/2021
1Teratoma (Teratoid Tumor)
12/2020
1Fasciitis (Fascitis)
01/2019
1Mouth Neoplasms (Oral Cancer)
01/2019
1Desmoplastic Fibroma
01/2019
1Lymphoma (Lymphomas)
01/2019
1Myofibroma
01/2019
1Sarcoma (Soft Tissue Sarcoma)
01/2019
1Periapical Granuloma
05/2018
1Granuloma
02/2018
1Alveolar Bone Loss
01/2013
1Periodontal Diseases (Periodontal Disease)
01/2013
1Necrosis
02/2012
1Granular Cell Tumor
02/2012

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
12/2022 - 06/2006
12Biological ProductsIBA
01/2022 - 08/2006
6Matrix Metalloproteinases (MMPs)IBA
12/2018 - 07/2008
4Capsules (Microcapsules)IBA
09/2022 - 07/2013
4Cadherins (E-Cadherin)IBA
01/2020 - 02/2009
4AntibodiesIBA
01/2019 - 06/2006
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 09/2008
3CateninsIBA
07/2019 - 06/2018
3VimentinIBA
01/2019 - 01/2007
3DesminIBA
01/2019 - 06/2011
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2018 - 09/2011
3Galectin 1 (LGALS1)IBA
05/2018 - 02/2012
3IntegrinsIBA
03/2013 - 06/2007
3Fibronectins (Fibronectin)IBA
02/2010 - 07/2004
3TenascinIBA
02/2010 - 07/2004
2EndonucleasesIBA
01/2021 - 08/2017
2EnzymesIBA
12/2020 - 12/2018
2Tryptases (Tryptase)IBA
01/2020 - 03/2011
2Metalloproteases (Metalloproteinases)IBA
12/2018 - 01/2013
2Biotin (Vitamin H)FDA Link
08/2017 - 06/2006
2Biomarkers (Surrogate Marker)IBA
08/2017 - 03/2013
2Glucose (Dextrose)FDA LinkGeneric
06/2017 - 10/2016
2Galectins (Galectin)IBA
09/2016 - 02/2013
2Extracellular Matrix ProteinsIBA
01/2013 - 02/2010
2Peptide Hydrolases (Proteases)FDA Link
07/2010 - 07/2008
2beta CateninIBA
03/2010 - 02/2009
1Plasminogen Activator Inhibitor 1IBA
01/2022
1Plasminogen Activators (Plasminogen Activator)IBA
01/2022
1X-ray Repair Cross Complementing Protein 1IBA
01/2021
1trans-sodium crocetinate (crocetin)IBA
12/2020
1Epidermal Growth Factor (EGF)IBA
12/2020
1AldehydesIBA
12/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2020
1Transcription Factors (Transcription Factor)IBA
11/2020
1Dihydrotachysterol (AT 10)IBA
04/2020
1CytokinesIBA
11/2019
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
11/2019
1Calmodulin-Binding Proteins (Caldesmon)IBA
01/2019
1Codon (Codons)IBA
01/2019
1Protein Kinases (Protein Kinase)IBA
01/2019
1GelatinasesIBA
12/2018
1CholesterolIBA
02/2018
1Vascular Endothelial Growth Factor CIBA
12/2016
1Carbonic Anhydrase IXIBA
10/2016
1Galectin 3 (LGALS3)IBA
09/2016
1methionylmethionine (Met-Met)IBA
04/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2013
1Carvedilol (Coreg)FDA LinkGeneric
01/2013
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
01/2013
1Atorvastatin (Lipitor)FDA Link
01/2013
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
01/2013
1Claudin-1IBA
12/2012
1Aligeron (AS 2)IBA
12/2012
1OsteoprotegerinIBA
03/2012
1RANK LigandIBA
03/2012
1Neurofilament ProteinsIBA
02/2012
1Tissue Inhibitor of Metalloproteinase-2IBA
10/2011
1EndoglinIBA
10/2011
1CollagenIBA
10/2011

Therapy/Procedure

4Oral Pathology
11/2022 - 02/2018
2Drug Therapy (Chemotherapy)
11/2020 - 11/2006
1Ligation
01/2013